ReShape Lifesciences to Host Fourth Quarter and Full Year 2019 Conference Call on March 26, 2020
Back to Newsroom
Mentioned in this Article

ReShape Lifesciences to Host Fourth Quarter and Full Year 2019 Conference Call on March 26, 2020

Monday, March 23, 2020 8:00 AM
Share this article now

SAN CLEMENTE, CA / ACCESSWIRE / March 23, 2020 / ReShape Lifesciences Inc. (OTCQB:RSLS), a leading developer and distributor of minimally invasive medical devices to treat obesity and metabolic diseases, today announced that it will host a conference call to discuss financial results for the fourth quarter and full year 2019 on Thursday, March 26, 2020 at 1:30 PM Pacific Time.

Individuals interested in listening to the conference call may do so by dialing (877) 280-7473 for domestic callers or (707) 287-9370 for international callers, using Conference ID: 7189904. To listen to a live webcast or a replay, please visit the investor relations section of the Company website at:

About ReShape Lifesciences Inc.

ReShape Lifesciences™ is a medical device company focused on technologies to treat obesity and metabolic diseases. The FDA-approved Lap-Band® Adjustable Gastric Banding System is designed to provide minimally invasive long-term treatment of severe obesity and is an alternative to more invasive surgical stapling procedures such as the gastric bypass or sleeve gastrectomy. The ReShape Vest™ System is an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach, emulating the gastric volume reduction effect of conventional weight-loss surgery, and is intended to enable rapid weight loss in obese and morbidly obese patients without permanently changing patient anatomy.

Investor Contact:

Tom Stankovich
Chief Financial Officer
ReShape Lifesciences Inc.
[email protected]

SOURCE: ReShape Lifesciences Inc.

ReShape Lifesciences Inc.
Back to Newsroom
Copyright 2020 © ACCESSWIRE. All rights reserved. Privacy Policy  |  Terms and Conditions
Drop us a line: